BIOTECHNOLOGY

PharmaEssentia Completes Patient Enrollment for Phase 2b EXCEED-ET Trial in Essential Thrombocythemia and Phase 3b ECLIPSE-PV Trial in Polycythemia Vera

“Myeloproliferative neoplasms, including ET and PV, are chronic blood diseases [...]

By |2024-06-25T17:02:37+00:00June 25, 2024|3rd Party Medical Device Industry News|Comments Off on PharmaEssentia Completes Patient Enrollment for Phase 2b EXCEED-ET Trial in Essential Thrombocythemia and Phase 3b ECLIPSE-PV Trial in Polycythemia Vera

Abu Dhabi Issues First BioTech Inventor-Class Golden Visa to Catalyze “Made-In-Abu-Dhabi IP” to Rockefeller University Inventor Dr Kambiz Shekdar, PhD

Dr Kambiz Shekdar said: “I gratefully take this opportunity as [...]

By |2024-05-24T16:27:41+00:00May 24, 2024|3rd Party Medical Device Industry News|Comments Off on Abu Dhabi Issues First BioTech Inventor-Class Golden Visa to Catalyze “Made-In-Abu-Dhabi IP” to Rockefeller University Inventor Dr Kambiz Shekdar, PhD
Go to Top